Mozes E, Sela M, Chedid L
Proc Natl Acad Sci U S A. 1980 Aug;77(8):4933-7. doi: 10.1073/pnas.77.8.4933.
The synthetic polypeptide antigen poly(LTyr, LGlu)-poly(DLAl)- -poly(LLys)[T,G)-A- -L] was covalently linked to N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP), which is the minimal adjuvant-active structure that can substitute for Mycobacteria in complete Freund's adjuvant. When injected in aqueous solution into mice, the completely synthetic conjugate elicited significant antibody responses specific to (T,G)-A- -L, whereas (T,G,)-A- -L alone administered under the same conditions did not lead to antibody production. The conjugate was much more efficient in eliciting (T,G)-A- -L responses than was a mixture of DMP and (T,G)-A- -L. One hundred micrograms of MDP mixed with 10 micrograms of (T,G)-A- -L resulted in production of (T,g)-A- -L-specific antibodies. However, the titers obtained were much lower than those observed with 10 micrograms of the conjugate, MDP-(T,G)-A- -L, which contained less than 1 microgram of MDP. MDP was enhanced when the mixture was administered in incomplete Freund's adjuvant, the adjuvant did not significantly affect the (T,G)-A- -L-specific antibody responses in mice immunized with MDP-(T,G)-A- -L. The isoelectric focusing pattern of antibodies obtained with MDP-(T,G)-A- -L was similar to that obtained after immunization with (T,G)-A- -L in complete Freund's adjuvant. The pattern of high-responder and low-responder mice to (T,G)-A- -L, the immune response to which is genetically controlled, was retained when MDP-(T,G)-A- -L was used as the immunogen. Conjugation of (T,G)-A- -L was creased the immunogenicity of MDP and affected its biological properties. It is thus possible to obtain efficient immune responses to synthetic polypeptide antigens that produce poor reactions when injected in aqueous solution by conjugating them to small molecular weight synthetic adjuvants.
合成多肽抗原聚(L-酪氨酸,L-谷氨酸)-聚(DL-丙氨酸)-聚(L-赖氨酸)[T,G)-A-L]与N-乙酰胞壁酰-L-丙氨酰-D-异谷氨酰胺(MDP)共价连接,MDP是可替代弗氏完全佐剂中分枝杆菌的最小佐剂活性结构。当将其以水溶液形式注射到小鼠体内时,这种完全合成的偶联物引发了针对(T,G)-A-L的显著抗体反应,而在相同条件下单独给予(T,G)-A-L则不会导致抗体产生。该偶联物在引发(T,G)-A-L反应方面比DMP和(T,G)-A-L的混合物更有效。100微克MDP与10微克(T,G)-A-L混合可产生(T,g)-A-L特异性抗体。然而,所获得的效价远低于用10微克偶联物MDP-(T,G)-A-L观察到的效价,该偶联物含有的MDP不到1微克。当混合物在不完全弗氏佐剂中给予时,MDP的佐剂作用增强,但该佐剂对用MDP-(T,G)-A-L免疫的小鼠中(T,G)-A-L特异性抗体反应没有显著影响。用MDP-(T,G)-A-L获得的抗体的等电聚焦图谱与用(T,G)-A-L在弗氏完全佐剂中免疫后获得的图谱相似。当使用MDP-(T,G)-A-L作为免疫原时,保留了对(T,G)-A-L的高反应性和低反应性小鼠模式,其免疫反应受遗传控制。(T,G)-A-L的偶联增加了MDP的免疫原性并影响其生物学特性。因此,通过将合成多肽抗原与小分子量合成佐剂偶联,可以获得对在水溶液中注射时反应不佳的合成多肽抗原的有效免疫反应。